All News

Robotic surgery is a promising option in the field of prostate cancer, leading to better outcomes and shorter hospital stays.

Optimizing the use of neoadjuvant chemotherapy could improve outcomes for patients with ovarian cancer.

Checkpoint inhibitors such as Opdivo and Yervoy are showing promise in treating MDS and AML.

Many patients with melanoma develop a resistance to targeted therapy, but new options to prevent resistance are being explored.

Respect the right of a patient with cancer to decide against treatment or to reach a point where fighting the disease is no longer worth the suffering.

Opdivo was approved for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

Fewer than half the women with advanced cervical cancer are receiving standard of care.

Rimas Lukas discusses the evolving field of glioblastoma multiforme (GBM) treatment.

Clutter clearing speaker/author turned two-time cancer survivor shares her holiday tips.

Holidays can be challenging, but here are a few helpful tips to surviving well.

Biomarkers have value in the diagnosis and monitoring of bladder cancer, but their use is still being perfected.

According to a recent trial, an immunotherapy combination was shown to be effective in high-risk melanoma. But because of the high toxicity profile, more research is needed.

In a word, everything.

Srdan Verstovsek, M.D., Ph.D. talks to CURE about recent advances in treating MPNs.

Geoffrey Sklar, M.D. talks about the successes of immunotherapy agents like Opdivo, and where this research is moving in the field of bladder cancer.

There is no doubt the Affordable Care Act needs tweaking. But let's not lose these critical pieces.

The Cancer Moonshot may not be gone forever after the presidential election, but how it will continue is still being discussed.

"Real Housewives of Beverly Hills" star Camille Grammer discusses how she worked to diminish the shame behind gynecologic cancers.

Genetics testing may help providers know which patients with breast cancer are at higher risk for venous thromboembolism (VTE).

A diagnosis of metastatic breast cancer can be frightening, but education and new treatments are helping these patients adjust to their "new normal."

Somatuline Depot is being explored for patients with lung neuroendocrine tumors.

Treatment advances, including a three-drug combo, are improving outcomes for patients with myeloma.

A recent study examined the link between depression and lung cancer outcomes in patients who are newly diagnosed.

Breast cancer patients with weakened immune systems need to be protected, especially during flu season.

A woman won a lawsuit against Johnson & Johnson, claiming that its baby powder caused her ovarian cancer.

CURE spoke with an expert on the importance of classifying T-cell lymphomas and what is next in this field.

Many female survivors of cancer face sexual pain after treatment, and may not feel comfortable starting a conversation with their health care providers.

A six-year breast cancer survivor and three-year melanoma survivor reflects back and offers hope.

Opdivo had positive results in patients with advanced bladder cancer according to findings from the CheckMate-275 trial.

The FDA granted ribociclib a priority review to a new drug application for certain patients with breast cancer.